A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

Clinical trial NCT06635057 · COMPLETED

Trial details

NCT number: NCT06635057
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-10-11
Primary completion: 2026-04-15
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.